| Primary |
| Hiv Infection |
70.8% |
| Drug Use For Unknown Indication |
8.0% |
| Antiretroviral Therapy |
4.5% |
| Product Used For Unknown Indication |
3.8% |
| Tuberculosis |
2.8% |
| Prophylaxis |
1.6% |
| Retroviral Infection |
1.6% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Drug Exposure During Pregnancy |
1.1% |
| Viral Infection |
0.7% |
| Pulmonary Tuberculosis |
0.6% |
| Systemic Antiviral Treatment |
0.6% |
| Bipolar Disorder |
0.5% |
| Metabolic Disorder |
0.5% |
| Pulmonary Embolism |
0.4% |
| Urinary Tract Infection |
0.4% |
| Attention Deficit/hyperactivity Disorder |
0.2% |
| Hepatitis C |
0.2% |
| Lipoatrophy |
0.2% |
| Pulmonary Hypertension |
0.2% |
|
| Vomiting |
19.1% |
| Rash |
13.5% |
| Pyrexia |
10.6% |
| Myocardial Infarction |
8.5% |
| Weight Decreased |
8.5% |
| Drug Exposure During Pregnancy |
7.8% |
| Immune Reconstitution Syndrome |
3.5% |
| Rash Maculo-papular |
3.5% |
| Upper Respiratory Tract Infection |
3.5% |
| Transaminases Increased |
2.8% |
| Viral Load Increased |
2.8% |
| Headache |
2.1% |
| Hypersensitivity |
2.1% |
| Jaundice |
2.1% |
| Urinary Tract Infection |
2.1% |
| Acute Myocardial Infarction |
1.4% |
| Brain Oedema |
1.4% |
| Chills |
1.4% |
| Dyspnoea |
1.4% |
| Haemolysis |
1.4% |
|
| Secondary |
| Hiv Infection |
61.4% |
| Antiretroviral Therapy |
9.5% |
| Drug Use For Unknown Indication |
6.0% |
| Drug Exposure During Pregnancy |
3.6% |
| Product Used For Unknown Indication |
3.2% |
| Prophylaxis |
2.7% |
| Human Immunodeficiency Virus Transmission |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.7% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Hepatitis C |
1.3% |
| Tuberculosis |
1.2% |
| Systemic Antiviral Treatment |
1.0% |
| Hypertension |
0.9% |
| Antifungal Prophylaxis |
0.8% |
| Hiv Test Positive |
0.8% |
| Insomnia |
0.6% |
| Oral Candidiasis |
0.6% |
| Gastritis |
0.5% |
| Antiviral Treatment |
0.5% |
| Mycobacterium Avium Complex Infection |
0.5% |
|
| Vomiting |
12.0% |
| Weight Decreased |
9.5% |
| White Blood Cell Count Decreased |
8.1% |
| Premature Baby |
7.4% |
| Myocardial Infarction |
7.1% |
| Drug Exposure During Pregnancy |
5.3% |
| Progressive External Ophthalmoplegia |
5.3% |
| Pancreatitis |
4.2% |
| Pregnancy |
4.2% |
| Urine Colour Abnormal |
4.2% |
| Varices Oesophageal |
3.9% |
| Joint Dislocation |
3.5% |
| Osteonecrosis |
3.5% |
| Parkinsonism |
3.5% |
| Drug Resistance |
3.2% |
| Portal Hypertension |
3.2% |
| Transplant Rejection |
3.2% |
| Rash |
2.8% |
| Rhabdomyolysis |
2.8% |
| Talipes |
2.8% |
|
| Concomitant |
| Hiv Infection |
60.4% |
| Drug Use For Unknown Indication |
7.4% |
| Product Used For Unknown Indication |
5.7% |
| Antiretroviral Therapy |
4.8% |
| Medical Diet |
3.8% |
| Antibiotic Prophylaxis |
2.4% |
| Prophylaxis |
2.3% |
| Antifungal Prophylaxis |
1.8% |
| Retroviral Infection |
1.5% |
| Vitamin Supplementation |
1.4% |
| Mineral Supplementation |
1.4% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Drug Exposure During Pregnancy |
0.9% |
| Hypertension |
0.9% |
| Folliculitis |
0.7% |
| Pneumocystis Jiroveci Pneumonia |
0.7% |
| Decreased Appetite |
0.7% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Insomnia |
0.6% |
| Tuberculosis |
0.6% |
|
| Vomiting |
13.4% |
| Contusion |
9.4% |
| Rhabdomyolysis |
9.1% |
| Weight Decreased |
7.5% |
| Drug Interaction |
5.5% |
| Renal Failure |
5.5% |
| Death |
5.1% |
| Renal Failure Acute |
5.1% |
| Renal Impairment |
4.3% |
| Viral Load Increased |
4.3% |
| Rash |
3.9% |
| Pyrexia |
3.5% |
| Treatment Noncompliance |
3.5% |
| Tremor |
3.5% |
| Rectal Haemorrhage |
3.1% |
| Renal Failure Chronic |
3.1% |
| Prothrombin Time Prolonged |
2.8% |
| Abortion Spontaneous |
2.4% |
| Cushing's Syndrome |
2.4% |
| Microcytic Anaemia |
2.4% |
|
| Interacting |
| Hiv Infection |
63.6% |
| Product Used For Unknown Indication |
18.2% |
| Liver Transplant |
9.1% |
| Hepatic Neoplasm Malignant |
3.0% |
| Immunosuppression |
3.0% |
| Tuberculosis |
3.0% |
|
| Abdominal Pain |
14.3% |
| Diarrhoea |
14.3% |
| Drug Metabolising Enzyme Test Abnormal |
14.3% |
| Sepsis |
14.3% |
| Tuberculosis |
14.3% |
| Tubulointerstitial Nephritis |
14.3% |
| Viraemia |
14.3% |
|
